Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens

International Journal for Parasitology

Volumn 37, Issue 13, 2007, Pages 1521-1529

  Ramamoorthy, Sheela ^a   Sanakkayala, Neelima ^b   Vemulapalli, Ramesh ^b   Duncan, Robert B ^a   Lindsay, David S ^a   Schurig, Gerhart S ^a   Boyle, Stephen M ^a   Kasimanickam, Ramanathan ^a   Sriranganathan, Nammalwar ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Brucella abortus strain RB51; Lethal challenge; Mice; Neospora caninum; Th1; Th2; Vaccine

Indexed keywords

BRUCELLA VACCINE; BRUCELLA VACCINE RB51; GAMMA INTERFERON; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 4; PARASITE ANTIGEN; PARASITE ANTIGEN GRA2; PARASITE ANTIGEN GRA6; PARASITE ANTIGEN MIC1; PARASITE ANTIGEN MIC3; PARASITE ANTIGEN SRS2; PROTOZOAL VACCINE; TACHYZOITE VACCINE; UNCLASSIFIED DRUG;

ANTIGEN; BACTERIUM; BRUCELLOSIS; CATTLE; DISEASE VECTOR; GENE EXPRESSION; INFECTIOUS DISEASE; PARASITE; PATHOGEN; PROTIST; PROTOZOAN; RODENT; VACCINATION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL STRAIN; BRUCELLA ABORTUS; C57BL 6 MOUSE; CELL LYSATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EXPERIMENTAL INFECTION; FEMALE; GENETIC RECOMBINATION; IMMUNITY; INOCULATION; NEOSPORA CANINUM; NONHUMAN; PROTEIN SECRETION; PROTOZOAL INFECTION; SPLEEN CELL; TACHYZOITE; TREATMENT OUTCOME; VACCINATION;

ANIMALS; ANTIGENS, PROTOZOAN; BRUCELLA ABORTUS; BRUCELLA VACCINE; FEMALE; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; NEOSPORA; SURVIVAL ANALYSIS;

BOS; BOVINAE; BRUCELLA MELITENSIS BIOVAR ABORTUS; MUS; NEOSPORA CANINUM;

EID: 34548697545     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2007.04.020     Document Type: Article

References (34)

1. Alaeddine F., Keller N., Leepin A., and Hemphill A. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1. J. Parasitol. 91 (2005) 657-665
2. Andrianarivo A.G., Choromanski L., McDonough S.P., Packham A.E., and Conrad P.A. Immunogenicity of a killed whole Neospora caninum tachyzoite preparation formulated with different adjuvants. Int. J. Parasitol. 29 (1999) 1613-1625
3. Baszler T.V., Long M.T., McElwain T.F., and Mathison B.A. Interferon-gamma and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice. Int. J. Parasitol. 29 (1999) 1635-1646
4. Baszler T.V., McElwain T.F., and Mathison B.A. Immunization of BALB/c mice with killed Neospora caninum tachyzoite antigen induces a type 2 immune response and exacerbates encephalitis and neurological disease. Clin. Diagn. Lab. Immunol. 7 (2000) 893-898
5. Cannas A., Naguleswaran A., Muller N., Eperon S., Gottstein B., and Hemphill A. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. Parasitology 126 (2003) 303-312
6. Cannas A., Naguleswaran A., Muller N., Gottstein B., and Hemphill A. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant. J. Parasitol. 89 (2003) 44-50
7. Cho J.H., Chung W.S., Song K.J., Na B.K., Kang S.W., Song C.Y., and Kim T.S. Protective efficacy of vaccination with Neospora caninum multiple recombinant antigens against experimental Neospora caninum infection. Korean J. Parasitol. 43 (2005) 19-25
8. Crawshaw W.M., and Brocklehurst S. Abortion epidemic in a dairy herd associated with horizontally transmitted Neospora caninum infection. Vet. Rec. 152 (2003) 201-206
9. Dubey J.P., Dorough K.R., Jenkins M.C., Liddell S., Speer C.A., Kwok O.C., and Shen S.K. Canine neosporosis: clinical signs, diagnosis, treatment and isolation of Neospora caninum in mice and cell culture. Int. J. Parasitol. 28 (1998) 1293-1304
10. Dubey J.P. Neosporosis in cattle: biology and economic impact. J. Am. Vet. Med. Assoc. 214 (1999) 1160-1163
11. Eperon S., Bronnimann K., Hemphill A., and Gottstein B. Susceptibility of B-cell deficient C57BL/6 (microMT) mice to Neospora caninum infection. Parasite Immunol. 21 (1999) 225-236
12. Haldorson G.J., Stanton J.B., Mathison B.A., Suarez C.E., and Baszler T.V. Neospora caninum: antibodies directed against tachyzoite surface protein NcSRS2 inhibit parasite attachment and invasion of placental trophoblasts in vitro. Exp. Parasitol. 112 (2006) 172-178
13. Hasler B., Stark K.D., Sager H., Gottstein B., and Reist M. Simulating the impact of four control strategies on the population dynamics of Neospora caninum infection in Swiss dairy cattle. Prev. Vet. Med. 77 (2006) 254-283
14. He X.L., Grigg M.E., Boothroyd J.C., and Garcia K.C. Structure of the immunodominant surface antigen from the Toxoplasma gondii SRS superfamily. Nat. Struct. Biol. 9 (2002) 606-611
15. Howe D.K., Crawford A.C., Lindsay D., and Sibley L.D. The p29 and p35 immunodominant antigens of Neospora caninum tachyzoites are homologous to the family of surface antigens of Toxoplasma gondii. Infect. Immun. 66 (1998) 5322-5328
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
17. Liddell S., Parker C., Vinyard B., Jenkins M., and Dubey J.P. Immunization of mice with plasmid DNA coding for NcGRA7 or NcsHSP33 confers partial protection against vertical transmission of Neospora caninum. J. Parasitol. 89 (2003) 496-500
18. Long M.T., Baszler T.V., and Mathison B.A. Comparison of intracerebral parasite load, lesion development, and systemic cytokines in mouse strains infected with Neospora caninum. J. Parasitol. 84 (1998) 316-320
19. McQuiston J.R., Schurig G.G., Sriranganathan N., and Boyle S.M. Transformation of Brucella species with suicide and broad host-range plasmids. Methods Mol. Biol. 47 (1995) 143-148
20. Miller C., Quinn H., Ryce C., Reichel M.P., and Ellis J.T. Reduction in transplacental transmission of Neospora caninum in outbred mice by vaccination. Int. J. Parasitol. 35 (2005) 821-828
21. Nishikawa Y., Kousaka Y., Fukumoto S., Xuan X., Nagasawa H., Igarashi I., Fujisaki K., Otsuka H., and Mikami T. Delivery of Neospora caninum surface protein, NcSRS2 (Nc-p43), to mouse using recombinant vaccinia virus. Parasitol. Res. 86 (2000) 934-939
22. Nishikawa Y., Tragoolpua K., Inoue N., Makala L., Nagasawa H., Otsuka H., and Mikami T. In the absence of endogenous gamma interferon, mice acutely infected with Neospora caninum succumb to a lethal immune response characterized by inactivation of peritoneal macrophages. Clin. Diagn. Lab. Immunol. 8 (2001) 811-816
23. Nishikawa Y., Xuan X., Nagasawa H., Igarashi I., Fujisaki K., Otsuka H., and Mikami T. Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene. Vaccine 19 (2001) 1710-1716
24. Quinn H.E., Miller C.M., and Ellis J.T. The cell-mediated immune response to Neospora caninum during pregnancy in the mouse is associated with a bias towards production of interleukin-4. Int. J. Parasitol. 34 (2004) 723-732
25. Ramamoorthy S., Lindsay D.S., Schurig G.G., Boyle S.M., Duncan R.B., Vemulapalli R., and Sriranganathan N. Vaccination with gamma-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum. J. Eukaryot. Microbiol. 53 (2006) 151-156
26. Ramamoorthy S., Duncan R., Lindsay D.S., and Sriranganathan N. Optimization of the use of C57BL/6 mice as a laboratory animal model for Neospora caninum vaccine studies. Vet. Parasitol. 145 3-4 (2007) 253-259
27. Rettigner C., Leclipteux T., De Meerschman F., Focant C., and Losson B. Survival, immune responses and tissue cyst production in outbred (Swiss white) and inbred (CBA/Ca) strains of mice experimentally infected with Neospora caninum tachyzoites. Vet. Res. 35 (2004) 225-232
28. Ritter D.M., Kerlin R., Sibert G., and Brake D. Immune factors influencing the course of infection with Neospora caninum in the murine host. J. Parasitol. 88 (2002) 271-280
29. Romero J.J., Perez E., and Frankena K. Effect of a killed whole Neospora caninum tachyzoite vaccine on the crude abortion rate of Costa Rican dairy cows under field conditions. Vet. Parasitol. 123 (2004) 149-159
30. Schares G., Peters M., Wurm R., Barwald A., and Conraths F.J. The efficiency of vertical transmission of Neospora caninum in dairy cattle analysed by serological techniques. Vet. Parasitol. 80 (1998) 87-98
31. Schurig G.G., Roop II R.M., Bagchi T., Boyle S., Buhrman D., and Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet. Microbiol. 28 (1991) 171-188
32. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA 76 (1979) 4350-4354
33. Vemulapalli R., He Y., Boyle S.M., Sriranganathan N., and Schurig G.G. Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses. Infect. Immun. 68 (2000) 3290-3296
34. Vemulapalli R., He Y., Cravero S., Sriranganathan N., Boyle S.M., and Schurig G.G. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect. Immun. 68 (2000) 3286-3289